Femistra Anastrazole (Arimidex) x 30

Made by Zydus Biogen

30 x 1mg tablets

Anastrozole 30 tabs x 1mg

Anazole is indicated for treatment of breast cancer in post-menopausal woman with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer. br>

Arimidex (anastrozole) is the aromatase inhibitor of choice. The drug is appropriately used when using substantial amounts of aromatizing steroids, or when one is prone to gynecomastia and using moderate amounts of such steroids. Arimidex does not have the side effects of aminoglutethimide (Cytadren) and can achieve a high degree of estrogen blockade, much moreso than Cytadren. It is possible to reduce estrogen too much with Arimidex, and for this reason blood tests, or less preferably salivary tests, should be taken after the first week of use to determine if the dosing is correct.

As an aromatase inhibitor, Arimidex’s mechanism of action — blocking conversion of aromatizable steroids to estrogen — is in contrast to the mechanism of action of anti-estrogens such as clomiphene (Clomid) or tamoxifen (Nolvadex), which block estrogen receptors in some tissues, and activate estrogen receptors in others. During a cycle, if using Arimidex, there is generally no need to use Clomid as well, but (as mentioned in the section on Clomid) there may still be benefits to doing so.

Arimidex at 0.5 mg/day is usually sufficient for moderate dosages of testosterone and in some cases may be too much.